OLD Second National Bank of Aurora Decreases Position in Danaher Corporation (DHR)
OLD Second National Bank of Aurora lowered its stake in shares of Danaher Corporation (NYSE:DHR) by 0.9% during the second quarter, Holdings Channel reports. The institutional investor owned 24,631 shares of the conglomerate’s stock after selling 230 shares during the period. OLD Second National Bank of Aurora’s holdings in Danaher Corporation were worth $2,079,000 as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. Peddock Capital Advisors LLC raised its position in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares in the last quarter. Proficio Capital Partners LLC increased its stake in Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after buying an additional 598 shares during the last quarter. ClariVest Asset Management LLC acquired a new stake in Danaher Corporation during the first quarter valued at approximately $157,000. Motco increased its stake in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock valued at $158,000 after buying an additional 390 shares during the last quarter. Finally, Baystate Wealth Management LLC increased its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock valued at $163,000 after buying an additional 60 shares during the last quarter. Hedge funds and other institutional investors own 76.12% of the company’s stock.
Shares of Danaher Corporation (NYSE:DHR) traded up 1.56% during midday trading on Wednesday, reaching $81.82. 1,407,769 shares of the company’s stock were exchanged. The firm has a 50-day moving average of $82.61 and a 200-day moving average of $84.26. The stock has a market capitalization of $56.84 billion, a P/E ratio of 26.12 and a beta of 1.03. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01.
Danaher Corporation (NYSE:DHR) last issued its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same period in the previous year, the company earned $0.90 earnings per share. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post $3.95 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This piece of content was originally published by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/16/old-second-national-bank-of-aurora-decreases-position-in-danaher-corporation-dhr.html.
Several research firms have recently commented on DHR. Jefferies Group LLC reissued a “buy” rating and set a $95.00 target price on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub downgraded shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 target price for the company in a research report on Friday, July 28th. Wells Fargo & Company reissued a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Finally, Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $91.76.
In other news, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the sale, the senior vice president now directly owns 39,020 shares in the company, valued at $3,283,923.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of Danaher Corporation stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the sale, the insider now owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders sold 38,623 shares of company stock valued at $3,206,426 over the last quarter. Company insiders own 12.20% of the company’s stock.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.